Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Clinical Outcomes Associated With Enzymatic Debridement of Diabetic Foot Ulcers for Up To 12 Weeks With Clostridial Collagenase (Santyl®) Ointment

NCT02111291 is registered in ClinicalTrials.gov with Healthpoint as lead sponsor.

NCT NCT02111291
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02111291 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Clinical Outcomes Associated With Enzymatic Debridement of Diabetic Foot Ulcers for Up To 12 Weeks With Clostridial Collagenase (Santyl®) Ointment
Lead sponsor
Healthpoint
Phase
Phase 4
Overall status
Completed
Start date
April 30, 2014
Completion date
December 31, 2015
Enrollment
215 (actual)
Sites
25

Conditions

As the registry lists them; a condition with its own page is linked.

diabetic foot ulcers, diabetic foot wounds